234 COMBINATION THERAPY WITH SUBEROYLANILIDE HYDROXAMIC ACID AND BORTEZOMIB INDUCES HISTONE ACETYLATION AND PROTEIN UBIQUITINATION SYNERGISTICALLY IN RENAL CANCER CELLS | Zendy

AI Assistant Blog Pricing

234 COMBINATION THERAPY WITH SUBEROYLANILIDE HYDROXAMIC ACID AND BORTEZOMIB INDUCES HISTONE ACETYLATION AND PROTEIN UBIQUITINATION SYNERGISTICALLY IN RENAL CANCER CELLS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.